March 19, 2025 11:09 AM EDT
Pharma

Pfiz­er ful­ly ex­its Sen­so­dyne mak­er Ha­le­on in $3.3B stake sale

Kyle LaHucik

Senior Reporter

Pfiz­er will get about $3.3 bil­lion from its fi­nal stake sale in Ha­le­on, ac­cord­ing to a Wednes­day fil­ing with the Lon­don …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

DOJ lawyers de­fend abor­tion pill re­stric­tions in new court fil­ing

Up­dat­ed: Im­muno­vant will not take rare dis­ease drug to reg­u­la­tors de­spite Phase 3 win

Ahead of FDA de­ci­sion, Al­ny­lam faces the big ques­tion: Can it make mon­ey?

Gilead stock slips as HHS de­nies re­ports of HIV fund­ing cuts

No­var­tis touts Zol­gens­ma da­ta in old­er kids as it read­ies reg­u­la­to­ry fil­ings

Re­genxbio shares new Duchenne gene ther­a­py da­ta ahead of big read­out next year

A service from the Financial Times